Background: The Canadian Network for Mood and Anxiety Treatments (CANMAT)
conducted a revision of the 2009 guidelines by updating the evidence and …

Sex hormones significantly impact women's lives. Throughout the different stages of life,
from menarche to menopause and all stages in between, women experience dramatic …

Objectives: To provide advice and guidance regarding the management of mood disorders,
derived from scientific evidence and supplemented by expert clinical consensus to formulate …

Depression exacts great emotional, social, and economic costs in the form of treatment
expenses, lost productivity, and emotional and social impairment. This is particularly …

Women are at a higher risk than men to develop mood disorders and depression. The
increased risk is associated with fluctuating estrogen levels that occur during reproductive …

The menopause transition is a dynamic process that begins with the first appearance of
menstrual irregularity and ends with a woman's final menstrual period. As ovarian follicle …

Background Gender differences, related to varying sexual hormone levels and hormone
secretion patterns across the lifespan, contribute to women's vulnerability to mood disorders …

Study Objectives: The aims of this study were:(1) to use a standardized psychiatric interview,
conducted by a trained psychologist to assess the prevalence of depression among patients …

The purpose of this study was to explore the antidepressant-like effects of vitamin D3 at
different doses (1.0, 2.5, and 5.0 mg/kg sc) on a model of depression produced by chronic …

Objectives Evaluation and management of anxiety and depression during the menopausal
transition are complicated by the overlap between some symptoms of affective disorder with …